Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastomaM N Gaze, J E Gains, C Walker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2017
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissueJennifer E Gains, Neil J Sebire, Veronica Moroz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastomaJayne S Wilson, Jennifer E Gains, Veronica Moroz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 5, 2018
The Evidence for External Beam Radiotherapy in High-Risk Neuroblastoma of Childhood: A Systematic ReviewS Arumugam, N J Manning-Cork, J E Gains, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN studyMark N Gaze, Tom Boterberg, Karin Dieckmann, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 28, 2020
Paediatric Molecular Radiotherapy: Challenges and OpportunitiesM D Aldridge, C Peet, S Wan, et al.
Nuclear Medicine Communications|August 16, 2020
68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapyJennifer E Gains, Matthew D Aldridge, Maria Vittoria Mattoli, et al.
Future Oncology (London, England)|March 9, 2013
Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastomaJennifer E Gains, Christopher Stacey, Ivan Rosenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
Nuclear Medicine Communications|October 22, 2021
Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapyCatherine A Taylor, Ananth Shankar, Mark N Gaze, et al.
Pageof 3